Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2026
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration RateRafal Yahya, Esben Iversen, Suvanjaa Sivalingam, et al.
Transplantation Proceedings|September 20, 2022
Post-Transplantation Anemia and Risk of Death Following Lung TransplantationTerese Brun Bugge, Michael Perch, Omid Rezahosseini, et al.
BMJ Open|April 30, 2013
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention studyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 11, 2024
Coronary angiography in patients with kidney dysfunction and myocardial injury: A retrospective cohort study on management of myocardial injury in hospitalized patients with kidney diseaseEmilie Illum, Dea Haagensen Kofod, Ellen Freese Ballegaard, et al.
Journal of General Internal Medicine|November 25, 2025
COVID-19 Vaccination and Kidney Disease : SARS-CoV-2 Vaccine Effect on Risk of Infection and Subsequent Outcomes in Patients with Chronic Kidney DiseaseNicholas Carlson, Felix Michalik, Thomas Gerds, et al.
Blood Purification|September 28, 2021
The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing HemodialysisTobias Bomholt, Marianne Rix, Thomas Almdal, et al.
Diabetes Care|August 19, 2015
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized TrialThomas Idorn, Filip K Knop, Morten B Jørgensen, et al.
Nephron|October 26, 2020
The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving DialysisTobias Bomholt, Thomas Idorn, Filip K Knop, et al.
Ugeskrift for Laeger|April 29, 2022
[SGLT2 inhibitorsfor treatment of chronic kidney disease without diabetes or heart failure]Bo Feldt-Rasmussen, Rikke Borg, Jan Carstens, et al.
Diabetes Care|February 25, 2016
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation DiabetesThea A S Halden, Erlend J Egeland, Anders Åsberg, et al.
Pageof 12